The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata.
메타분석
4/5 보강
TL;DR
Despite divergent opinions amongst experts, consensus was achieved on a number of pertinent questions and the concluding statement highlights areas where expert consensus is lacking and where an international patient registry could enable further research.
📑 코퍼스 인용 관계
· 인용됨 76
📑 인용한 논문 (6) ▾
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alo… Cureus · 2026
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Rev… Indian dermatology online journal · 2026
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024. Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
- Mechanistic study of Erianin in alopecia areata. American journal of translational research · 2025
- Mechanism of PPARα agonist in alopecia areata. American journal of translational research · 2025
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata. Biomedicines · 2025
연도별 인용 (2012–2026) · 합계 197
OpenAlex 토픽 ·
Hair Growth and Disorders
Acne and Rosacea Treatments and Effects
Facial Rejuvenation and Surgery Techniques
Abstract 🌐 Abstract
[BACKGROUND] A systematic review failed to identify any systemic therapy used in alopecia areata (AA) where use is supported by robust evidence from high-quality randomized controlled trials.
[OBJECTIVE] To produce an international consensus statement on the use and utility of various treatments for AA.
[METHODS] Fifty hair experts from 5 continents were invited to participate in a 3-round Delphi process. Agreement of 66% or greater was considered consensus.
[RESULTS] In the first round, consensus was achieved in 22 of 423 (5%) questions. After a face-to-face meeting in round 3, overall, consensus was achieved for only 130 (33%) treatment-specific questions. There was greater consensus for intralesional treatment of AA (19 [68%]) followed by topical treatment (25 [43%]). Consensus was achieved in 45 (36%) questions pertaining to systemic therapies in AA. The categories with the least consensus were phototherapy and nonprescription therapies.
[LIMITATIONS] The study included a comprehensive list of systemic treatments for AA but not all treatments used.
[CONCLUSION] Despite divergent opinions among experts, consensus was achieved on a number of pertinent questions. The concluding statement also highlights areas where expert consensus is lacking and where an international patient registry could enable further research.
[OBJECTIVE] To produce an international consensus statement on the use and utility of various treatments for AA.
[METHODS] Fifty hair experts from 5 continents were invited to participate in a 3-round Delphi process. Agreement of 66% or greater was considered consensus.
[RESULTS] In the first round, consensus was achieved in 22 of 423 (5%) questions. After a face-to-face meeting in round 3, overall, consensus was achieved for only 130 (33%) treatment-specific questions. There was greater consensus for intralesional treatment of AA (19 [68%]) followed by topical treatment (25 [43%]). Consensus was achieved in 45 (36%) questions pertaining to systemic therapies in AA. The categories with the least consensus were phototherapy and nonprescription therapies.
[LIMITATIONS] The study included a comprehensive list of systemic treatments for AA but not all treatments used.
[CONCLUSION] Despite divergent opinions among experts, consensus was achieved on a number of pertinent questions. The concluding statement also highlights areas where expert consensus is lacking and where an international patient registry could enable further research.
- 연구 설계 systematic review
Despite divergent opinions amongst experts, consensus was achieved on a number of pertinent questions and the concluding statement highlights areas where expert consensus is lacking and where an inter
APA 7
Meah, N., Wall, D., York, K., Bhoyrul, B., Bokhari, L., Sigall, D. A., Bergfeld, W. F., Betz, R. C., Blume-Peytavi, U., Callender, V., Chitreddy, V., Combalia, A., Cotsarelis, G., Craiglow, B., Donovan, J., Eisman, S., Farrant, P., Green, J., Grimalt, R., Harries, M., & ... (2020). The alopecia areata consensus of experts (ace) study: Results of an international expert opinion on treatments for alopecia areata.. Journal of the American Academy of Dermatology, 83(1), 123-130. https://doi.org/10.1016/j.jaad.2020.03.004
Vancouver
Meah N, Wall D, York K, Bhoyrul B, Bokhari L, Sigall DA, et al. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. Jour. Amer. Acad. Derm.. 2020;83(1):123-130. doi:10.1016/j.jaad.2020.03.004
AMA 11
Meah N, Wall D, York K, Bhoyrul B, Bokhari L, Sigall DA, et al. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. Jour. Amer. Acad. Derm.. 2020;83(1):123-130. doi:10.1016/j.jaad.2020.03.004
Chicago
Meah, N., Wall, D., York, K., Bhoyrul, B., Bokhari, L., Sigall, D. A., Bergfeld, W. F., Betz, R. C., Blume-Peytavi, U., Callender, V., and .... 2020. "The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata." Journal of the American Academy of Dermatology 83 (1): 123-130. https://doi.org/10.1016/j.jaad.2020.03.004
MLA 9
Meah, N., et al. "The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata." Journal of the American Academy of Dermatology, vol. 83, no. 1, 2020, pp. 123-130. doi:10.1016/j.jaad.2020.03.004.
PMID
32165196 ↗
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | alopecia areata
|
원형 탈모증 | dict | 3 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 7/8 (88%)
· 참조 0편 · 후속 7편
이 논문을 인용한 후속 연구 20
- Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
- Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implicatio…
- Alopecia Areata: Current Treatments and New Directions.
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis…
- Alopecia Areata: An Updated Review for 2023.
- Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Pop…
- Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inf…
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata.
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descr…
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Revie…
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review.
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review.
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA.
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analy…
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Re…
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).
- Treatment Options for Alopecia Areata in Children and Adolescents.
- Hair regrowth in alopecia areata and re-pigmentation in vitiligo in response to treatment: Commonali…
같은 제1저자의 인용 많은 논문 (3)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Alopecia areata.
TL;DRAlopecia areata is difficult to manage medically, but recent advances in understanding the molecular mechanisms have revealed new treatments and the possibility of remission in the…
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
TL;DRIn two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…
-
Hair follicle immune privilege and its collapse in alopecia areata.
TL;DRA key goal for effective AA management is the re‐establishment of a functional HF IP, which will also provide superior protection from disease relapse, and may confer increased sus…